MedTrace Logo

PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations

NCT05854901 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 693

Last updated 2023-05-11

No results posted yet for this study

Summary

This study the investigators will examine whether procalcitonin-guided treatment regarding antibiotic therapy is non-inferior to usual care in patients who are admitted because of an acute COPD exacerbation when it comes to treatment failure on day 30.

Conditions

  • COPD Exacerbation
  • COPD
  • Acute Copd Exacerbation

Interventions

DIAGNOSTIC_TEST

Procalcitonin

blood test, measuring the concentration of PCT in ug/L

OTHER

Physician's decision

The physician's decided whether the patient will receive antibiotic treatment or not

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Menno M van der Eerden, MD, PhD · Erasmus Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-10
Primary Completion
2025-02-28
Completion
2025-02-28

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05854901 on ClinicalTrials.gov